Switch to:
More From Other Websites
Health Care: Some Healthy Bargains Still Remain Oct 01 2014
BioMed Leases Space to Baxter for R&D Center in MA Sep 30 2014
Baxter plans to open R&D center in Mass. for Baxalta spinoff Sep 29 2014
Baxter to Form New Global Innovation and R&D Center near Boston for Its Biopharmaceuticals Business Sep 29 2014
Kamada extends emphysema drug deal with Baxter through 2017 Sep 29 2014
[video] Shah Favors Big Pharmaceuticals Focused on Obesity Sep 26 2014
PharmaEngine and Merrimack Amend MM-398 License Agreement Sep 26 2014
Baxter International Third Quarter 2014 Financial Results Conference Call Sep 25 2014
Baxter and Merrimack Collaborate on Drug Development Sep 25 2014
Stocks Gain While Dollar Reaches Highest Level Since 2010 Sep 24 2014
Why Merrimack Pharmaceuticals (MACK) Stock Hit a One-Year High Today Sep 24 2014
Merrimack, Baxter to collaborate on cancer drug Sep 24 2014
Merrimack, Baxter to collaborate on cancer drug Sep 24 2014
US STOCKS-Wall St set for modest gains at open after three-day slump Sep 24 2014
Merrimack Does Well to License Marginal Cancer Drug to Baxter Sep 24 2014
Baxter to market Merrimack's cancer drug outside U.S. Sep 24 2014
Merrimack Pharma shares surge on licensing pact with Baxter Sep 24 2014
[$$] Baxter, Merrimack to Collaborate on Pancreatic Cancer Drug Sep 24 2014
Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing Agreement to Develop and... Sep 24 2014
Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing Agreement to Develop and... Sep 24 2014
BAX, COV And MDT, Pushing Health Services Industry Downward Sep 17 2014
Baxter and Halozyme Therapeutics Get FDA Approval Sep 15 2014
FDA Approves Baxter’s RIXUBIS [Coagulation Factor IX (Recombinant)] for Treatment of Children with... Sep 15 2014
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency Sep 12 2014
Momenta Gains on Purchase of Autoimmune Antibodies Sep 11 2014
Baxter Names its New Spun-off Biopharmaceuticals Company Sep 11 2014
Health care company expanding in Alabama Aug 20 2014
Baxter Opens Its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with... Aug 07 2014
Pfizer buying two Baxter vaccines for $635M Jul 30 2014
Baxter Highlights Commitment to Innovation and Focus on Improving Patient Outcomes at WFH World... May 12 2014
Baxter splitting into 2 separate businesses Mar 27 2014
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies Mar 27 2014
Exclusive - Baxter explores sale of its vaccines business: sources Mar 26 2014
Danone could spend Medical Nutrition cash on baby food, dairy deals Mar 07 2014
Baxter to Present at Barclay’s Global Healthcare Conference Feb 27 2014
Baxter Presents Data at EAHAD from Long-Term Outcomes Registry Reinforcing Prophylaxis Treatment... Feb 27 2014
Fresenius eyes bid for Danone tube feeding products arm - sources Feb 19 2014
Baxter Declares Quarterly Dividend Feb 18 2014
Baxter to Present at Cowen & Company’s 34th Annual Health Care Conference Feb 13 2014
Baxter to Present at Upcoming Global Healthcare Conferences Feb 10 2014
Shri Ghulam Nabi Azad Inaugurates Baxter Global Research Center at Syngene... Feb 05 2014
Baxter Announces Restructured Agreement with Xenetic Biosciences, Further Bolstering Its Broad... Jan 30 2014
Baxter Reports Fourth Quarter 2013 Financial Results in Line with Expectations Jan 23 2014
Baxter to Present at 32nd Annual J.P. Morgan Healthcare Conference Jan 06 2014
Baxter International Fourth Quarter 2013 Financial Results Conference Call Jan 06 2014
Baxter Completes CE Mark Approval for VIVIA Hemodialysis System in Europe Dec 20 2013
Baxter Receives FDA Approval of FEIBA [Anti-Inhibitor Coagulant Complex] for Prophylactic Treatment... Dec 19 2013
Baxter Submits Application for FDA Approval of OBI-1 for Patients with Acquired Hemophilia A Dec 10 2013
Baxter Submits Amended BLA to U.S. FDA for HyQvia for Primary Immunodeficiency Dec 02 2013
Baxter Submits Amended BLA to U.S. FDA for HyQvia for Primary Immunodeficiency Dec 02 2013
Dow closes above 15,000 for first time May 07 2013


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Sww
ReplySww - 3 months ago
Bax medical devices revenue ~9b, bio science ~7b
using 3X sales of medical devices company and 4X for drugs company, 27b+28b = 55b market cap,as of June 2014, BAX market cap is 39b, so it can sell for

72 * (1 + 16/39) = 99

72 is current stock price, with an upside of around 35%

so my guess is BAX may be able to sell for around 90 after spin-off.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK